We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

155 hedge funds and large institutions have $1.62B invested in Select Medical in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 55 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $1.44B → $1.62B (+$189M)

7% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 55

2.44% less ownership

Funds ownership: 150.37%147.93% (-2.4%)

5% less funds holding

Funds holding: 164155 (-9)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

Holders
155
Holders Change
-9
Holders Change %
-5.49%
% of All Funds
3.86%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
51
Reduced
55
Closed
23
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$56K
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
176
Simplex Trading
Illinois
-$1K -208 Closed
SEI Investments
177
SEI Investments
Pennsylvania
+$165 +22 New

SEM Hedge Fund Activity: Q2 2017 in Review

155 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2017, worth a combined $1.62B — up 13% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SEM and 14 opened new positions — a net loss of 9 holders — while 55 trimmed existing stakes and 51 added.

The largest buyer was OrbiMed, adding an estimated $22.3M. The largest seller was LSV Asset Management, exiting entirely with an estimated $30.1M sold.

  • 155 institutional investors held Select Medical (SEM) as of Q2 2017, down from 164 in Q1 2017.
  • Funds reported $1.62B of Select Medical stock for Q2 2017, up 13% quarter-over-quarter.
  • 14 funds opened new Select Medical positions in Q2 2017 and 23 closed out, a net change of -9 holders.
  • The largest Select Medical buyer in Q2 2017 was OrbiMed, an estimated $22.3M added.
  • The largest Select Medical seller in Q2 2017 was LSV Asset Management, an estimated $30.1M sold.

Based on aggregated 13F filings for Q2 2017.